Mar Haz‐Conde

662 citations
14 papers · 519 indexed · h-index 12
Topics
Cancer Cells and Metastasis (6 papers)Cancer-related molecular mechanisms research (4 papers)MicroRNA in disease regulation (4 papers)
Partner nations
SpainUnited States

In The Last Decade

Mar Haz‐Conde

14 papers receiving 506 citations

Peers

Mar Haz‐Conde
Comparison fields: 5 of 61
  • Molecular Biology 391
  • Cancer Research 289
  • Oncology 126
  • Pulmonary and Respiratory Medicine 41
  • Cell Biology 39
Replace Yi‐Fang Yang with:
Yi‐Fang Yang Taiwan
Xianju Qin China
Tjarda van Heek Netherlands
Ailan Cheng China
Lihong Yin United States
Micaela Montanari Italy
Mingchen Zhu China
Shauntae M. McDaniel United States
Qiji Li China
Hiroko Kitahara Japan
Mar Haz‐Conde relative to Yi‐Fang Yang Taiwan Yi‐Fang Yang's profile →
Citations per field
00.5×4.1×
Yi‐Fang Yang · 1×
Citations per year

Countries citing papers authored by Mar Haz‐Conde

Since Specialization
Citations

This map shows the geographic impact of Mar Haz‐Conde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mar Haz‐Conde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mar Haz‐Conde more than expected).

Fields of papers citing papers by Mar Haz‐Conde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mar Haz‐Conde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mar Haz‐Conde. The network helps show where Mar Haz‐Conde may publish in the future.

Co-authorship network of co-authors of Mar Haz‐Conde

This figure shows the co-authorship network connecting the top 25 collaborators of Mar Haz‐Conde. A scholar is included among the top collaborators of Mar Haz‐Conde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mar Haz‐Conde. Mar Haz‐Conde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 78
2 19
3 41
4 32
5 134
6 1
7 41
8 31
9 45
10 25
11 19
12 16
13 9
14 28

About Mar Haz‐Conde

Mar Haz‐Conde is a scholar working on Cancer Research, Oncology and Molecular Biology, having authored 14 papers that have together received 519 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Cancer-related molecular mechanisms research (4 papers) and MicroRNA in disease regulation (4 papers). The work is most often cited by research in Cancer Research (289 citations), Molecular Biology (391 citations) and Oncology (126 citations). Mar Haz‐Conde has collaborated with scholars based in Spain and United States. Frequent co-authors include Angélica Figueroa, Manuel Valladares‐Ayerbes, M. Blanco, Luis Antón-Aparicio, Lourdes Calvo, María José Lorenzo-Patiño, Isabel Santamarina, Margarita Reboredo, Luís Antón Aparicio and María Quindós. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026